We have identified some errors in the Hanyang Securities research report released without prior consultation with us, and we are providing corrections and notifications.

The corrected content encompasses three major areas as follows.

[Corrections]

Regarding factory utilization rate (Before correction): Factory utilization rate 285% (After correction): Production volume of functional peptides increased by 285% compared to the plan.

Related to DNF-10 (Before correction): Approved as an individually recognized ingredient by the Ministry of Food and Drug Safety (After correction): Removed.

Description concerning DNF-10 (Before correction): DNF-10 is described as "a simple nutritional supplement" (After correction): Removed.

Here we post the corrected Hanyang Securities research.

Download the corrected Hanyang Securities research file.